(12-186) Evaluation of Recombinant Activated Factor VII versus 4-Factor Prothrombin Complex Concentrate for the Treatment of Refractory Bleeding in Cardiothoracic Surgery Patients
Wednesday, December 10, 2025
2:00 PM - 3:00 PM
Location: Bayside A, Level 1
Residency Program: TriHealth – Bethesda North Hospital Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Ohio
